The [14C-N-methyl]-erythromycin breath test dosimetry complies with the French regulations for radiation safety

Fundamental and Clinical Pharmacology

Volumn 17, Issue 3, 2003, Pages 349-353

  Salvat, Cécile ^a   Mouly, Stéphane ^a   Rizzo Padoin, Nathalie ^a   Knellwolf, Anne Laure ^a   Simoneau, Guy ^a   Duet, Michèle ^a   Nataf, Valérie ^a   Bailliart, Olivier ^a   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cytochrome P450 3A4; Erythromycin breath test; Radiation safety

Indexed keywords

CARBON 14; ERYTHROMYCIN; CARBON;

ARTICLE; BIOSAFETY; BREATH ANALYSIS; CLINICAL RESEARCH; DOSIMETRY; DRUG DOSE REGIMEN; DRUG LABELING; HUMAN; INHALATION; INTERMETHOD COMPARISON; LABORATORY PERSONNEL; MAXIMUM ALLOWABLE CONCENTRATION; NATURAL RADIOACTIVITY; PRIORITY JOURNAL; RADIATION EXPOSURE; ANIMAL; FRANCE; LEGAL ASPECT; METHODOLOGY; OCCUPATIONAL EXPOSURE; RADIOLOGY; RADIOMETRY; SAFETY; STANDARD;

ANIMALS; BREATH TESTS; CARBON RADIOISOTOPES; ERYTHROMYCIN; FRANCE; HUMANS; LABORATORY PERSONNEL; OCCUPATIONAL EXPOSURE; RADIOLOGY; RADIOMETRY; SAFETY;

EID: 0038095542     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00139.x     Document Type: Article

References (20)

1. Von Moltke L.L., Greenblatt D.J., Schmider J., Harmartz J.S., Shader R.I. Metabolism of drugs by cytochrome P4503A isoforms. Clin. Pharmacokinet. (1995) 29 (Suppl.) 33-44.
2. Piscitelli S.C., Gallicano K.D. Interactions among drugs for HIV and opportunistic infections. N. Engl. J. Med. (2001) 344 984-996.
3. Lown K.S., Thummel K.E., Benedict P.E. et al. The erythromycin breath test predicts the clearance of midazolam. Clin. Pharmacol. Ther. (1995) 57 16-24.
4. Watkins P.B., Murray S.A., Winkelman L.G., Heuman D.M., Wrighton S.A., Guzelian P.S. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochome P-450. Studies in rat and patients. J. Clin. Invest. (1989) 83 688-697.
5. Watkins P.B. Non-invasive tests of CYP3A enzymes. Pharmacogenetics (1994) 4 171-184.
6. INRS-Carbone 14. Fiche technique de radioprotection pour l'utilisation de radionucléides en sources non scellées. Service Central de Protection contre les Rayonnements Ionisants (1993).
7. Watkins P.B. Erythromycin breath test and clinical transplantation. Ther. Drug. Monit. (1996) 18 368-371.
8. Hirth J.A., Watkins P.B., Strauwderman M., Schott A., Bruno R., Baker L. The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. Clin. Cancer. Res. (2000) 6 1255-1258.
9. Cheng C.L., Smith D.E., Carver P.L. et al. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin. Pharmacol. Ther. (1997) 61 531-543.
10. Slain D., Pakyz A., Israel D.S., Monroe S., Polk R.E. Variability in activity of hepatic CYP3A4 in patients infected with HIV. Pharmacotherapy (2000) 20 898-907.
11. 14C. Health Phys. (1996) 70 418-424.
12. Mouly S., Aymard G., Diquet B., Caulin C., Bergmann J.F. Oral ganciclovir systemic exposure is enhanced in human immunodeficiency virus (HIV)-infected patients with diarrhea and weight loss. J. Acquired. Immune. Def. Synd. (2000) 24 344-352.
13. 14C]-erythromycin A. Eur. J. Metab. Pharmacokinet. (1989) 14 7-14.
14. Cristy M., Eckerman K. Specific absorbed fractions of energy at various ages from internal photons sources. ORNL/TM-8381 V1-V7 Oak Ridge Oak Ridge National Laboratory. Oak Ridge, 1987.
15. Wilson J.T., Van Boxtel C.J. Pharmacokinetics of erythromycin in man. Antibiotics Chemother. (1978) 25 181-203.
16. Bottolier-Depois J.F., Charmasson S., Foulquier L. et al. Repères Sixth International Symposium on the Natural Radiation Environment (NRE-VI). Montreal. Quebec. Canada. 5-6 June. 1995.
17. Commissariat à l'énergie atomique. Expositions aux rayonnements ionisants (hors activités professionnelles). Répartition des différentes expositions aux rayonnements de la population française. Informations utiles-CEA. (1998) 10 45-50.
18. Rayonnements ionisants et radioprotection. Comment situer l'importance d'une dose d'irradiation? Le Manipulateur (1999) Numero special 48.
19. Grognet J.M., Mazière B. Utilization des radio-isotopes dans les essais cliniques avec ou sans bénéfice individuel direct. La lettre du Pharmacologue (1997) 11 83-85.
20. Mouly S., Lown K.S., Wille R.T. et al. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans. Clin. Pharmacol. Ther. (2002) 72 1-9.